Osprey Pharmaceuticals USA

About:

Osprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.

Website: http://www.ospreypharma.com

Top Investors: Novo Nordisk, BDC Venture Capital, Western Technology Investment, Desjardins Venture Capital, MMV Capital Partners

Description:

Osprey Pharmaceuticals USA is a clinical stage company focused on the development of novel protein therapeutics for the treatment of inflammatory and immune diseases. The company is advancing a pipeline of proprietary fusion protein therapeutics known as Leukocyte Population Modulators (LPMs) that are designed to selectively target and neutralize chemokine-activated leukocytes underlying a variety of inflammatory and immune diseases. The Company’s lead candidate, CCL2-LPM targeting the CCR2 chemokine receptor expressed by certain pathologically activated leukocytes is in a Phase Ib clinical trial for the treatment of IgA nephropathy.